36. 表皮水疱症 Epidermolysis bullosa Clinical trials / Disease details

臨床試験数 : 163 / 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03786237 (ClinicalTrials.gov)	April 12, 2021	14/11/2018	Rigosertib for RDEB-SCC	A Phase II, Open Study to Assess Efficacy and Safety of Rigosertib in Patients With Recessive Dystro ...	Epidermolysis Bullosa Dystrophica;Squamous Cell Carcinoma	Drug: Rigosertib Oral Capsules / Rigosertib Intravenous	Prof. Johann Bauer	NULL	Recruiting	18 Years	79 Years	All	12	Phase 1/Phase 2	Austria